KOVAX® 971-00948 Interface Pad, 70 mm W x 125 mm L, Super-Tack Attachment

KOVAX® 971-00948 Interface Pad, 70 mm W x 125 mm L, Super-Tack Attachment

Marsoni

M251S

$18.18

Get it in 3 business days with 1 day shipping. Friday, May 29

KOVAX® 971-00948 Interface Pad, 70 mm W x 125 mm L, Super-Tack AttachmentProduct Description Extra hard construction interface pad designed to be used with coarser grit of Super Assilex sheets for a more uniform block sanding effect. Ideal for use with foam block (part no. 00212). Features Durable More uniform blocking effect Specifications More Information Part No. 971 00948 Product Line EAG MFR Model 971 00948 Manufacturer Eagle Abrasives UPC 4934446057884 Brand KOVAX Part Status A Length (mm) 125 Width (mm) 70

Easy Shipping

Quick Dispatch:

Your KOVAX® 971-00948 Interface Pad, 70 mm W x 125 mm L, Super-Tack Attachment orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your KOVAX® 971-00948 Interface Pad, 70 mm W x 125 mm L, Super-Tack Attachment ships.

Need Help?
Questions about KOVAX® 971-00948 Interface Pad, 70 mm W x 125 mm L, Super-Tack Attachment, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for KOVAX® 971-00948 Interface Pad, 70 mm W x 125 mm L, Super-Tack Attachment in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Felt lost while going into Ortho Sub-Is, but this book was a great quick review before going into them. It served well to give context to the field, but definitely not enough for a thorough review for sub-Is. If you are not in medical school, this book might be more apt for you. Overall, love the cartoon and definitely helped me some questions right on intense pimp sessions.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on August 12, 2019

Verified Purchase

J in FLA

Boise, US

★★★★★ 5

Med school orthopedics (basic orthopedics) presented in an easy to understand format.

Format: Paperback

This book is well written and easy to follow. I'm a fan of this publishers "Clinical Pathology Made Ridiculously Simple," and I found this book to be similar in presentation. This is a good book for Medical and PA students during their orthopedic didactic curriculum, and as a review before an orthopedic rotation, but it's a little too basic to be the only book you read during your orthopedic clerkship (for clerkship, I recommend also reading Case Files Orthopaedic Surgery).This is a good book to review orthopedic concepts for board exams. It's also a good book for primary care residents and primary care mid-level providers who want to brush up on ortho.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on September 9, 2013

Verified Purchase

nickel

Draper, US

★★★★★ 5

It is very concise with many illustrations and fun to read

Format: Paperback

using this book to study for the ONC cert exam. It is very concise with many illustrations and fun to read. I'll update my review after I take the exam

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on December 28, 2015

Verified Purchase

Amazon Customer

Pawtucket, US

★★★★★ 5

Thanks

Format: Paperback

Thanks

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on November 19, 2023

Verified Purchase

Leanne

Natrona Heights, US

★★★★★ 3

Multiple Myeloma

Format: Paperback

In the next edition please include a section on the dreaded bone cancer called multiple myeloma. Too many Orthopedic people, including physical therapists, often misdiagnose MM and blame it on arthritis.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on May 22, 2024